We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LSEA
10076
DELISTED
Landsea Homes
LSEA
$255K ﹤0.01%
+38,172
New +$298K
OTTR icon
10077
PUT
Otter Tail
OTTR
$3.9B
$255K ﹤0.01%
+3,800
New +$242K
GGRP
10078
PUT
Glimpse Group
GGRP
$19.6M
$255K ﹤0.01%
64,100
-15,700
-20% -$69.1K
VBIV
10079
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$255K ﹤0.01%
10,513
+3,574
+52% +$122K
EMFM
10080
DELISTED
Global X MSCI Next Emerging & Frontier ETF
EMFM
$255K ﹤0.01%
+13,880
New +$281K
APEN
10081
DELISTED
Apollo Endosurgery, Inc.
APEN
$255K ﹤0.01%
69,807
+39,466
+130% +$187K
BLFS icon
10082
PUT
BioLife Solutions
BLFS
$1.72B
$254K ﹤0.01%
18,400
+2,900
+19% +$42.6K
FC icon
10083
PUT
Franklin Covey
FC
$229M
$254K ﹤0.01%
+5,500
New +$219K
SPXC icon
10084
PUT
SPX Corp
SPXC
$10.9B
$254K ﹤0.01%
4,800
+100
+2% +$4.83K
XXII
10085
CALL
22nd Century Group
XXII
$1.49M
0
EATV
10086
DELISTED
VegTech Food Innovation & Climate ETF
EATV
$254K ﹤0.01%
+15,363
New +$277K
ABOS icon
10087
Acumen Pharmaceuticals
ABOS
$193M
$253K ﹤0.01%
53,749
-99,498
-65% -$374K
AGYS icon
10088
Agilysys
AGYS
$3.22B
$253K ﹤0.01%
+5,355
New +$209K
AREC icon
10089
PUT
American Resources Corp
AREC
$308M
$253K ﹤0.01%
174,700
-18,800
-10% -$33.5K
ATER icon
10090
Aterian
ATER
$5.44M
$253K ﹤0.01%
+9,763
New +$432K
BV icon
10091
CALL
BrightView Holdings
BV
$1.09B
$253K ﹤0.01%
21,100
-700
-3% -$8.77K
CATO icon
10092
PUT
Cato Corp
CATO
$67.9M
$253K ﹤0.01%
21,800
+2,100
+11% +$27.6K
CMPR icon
10093
PUT
Cimpress
CMPR
$2.3B
$253K ﹤0.01%
6,500
+2,100
+48% +$102K
CSR
10094
Centerspace
CSR
$938M
$253K ﹤0.01%
3,100
-47,380
-94% -$4.15M
GLAD icon
10095
CALL
Gladstone Capital
GLAD
$446M
$253K ﹤0.01%
12,550
-550
-4% -$12.5K
EVA
10096
DELISTED
Enviva Inc.
EVA
$253K ﹤0.01%
4,409
-3,666
-45% -$276K
POL
10097
DELISTED
Polished.com Inc.
POL
$253K ﹤0.01%
4,153
+3,352
+418% +$247K
RESP
10098
DELISTED
WisdomTree U.S. ESG Fund
RESP
$253K ﹤0.01%
+6,209
New +$274K
PACW
10099
PUT
DELISTED
PacWest Bancorp
PACW
$253K ﹤0.01%
9,500
-39,200
-80% -$1.27M
SBDS
10100
DELISTED
Solo Brands Inc
SBDS
$253K ﹤0.01%
1,559
-887
-36% -$194K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.